A recent work [13] has identified subgroups of individuals with differential risk for other cardiometabolic traits, e.g., fasting insulin, fasting glucose, waist-hip ratio (WHR), body mass index (BMI), TG, and HDL, helping to account for the observed clinical heterogeneity in T2D. Here, INS is linked to type 2 diabetes mellitus.